CYNTHIA FULLBRIGHT: Open Payments
NPI 1598858268 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 60 payments from 13 companies in 2025. Trend: 2023 $835 · 2024 $1,345 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $293 |
| E.R. Squibb & Sons, L.L.C. | 12 | $245 |
| Merck Sharp & Dohme LLC | 8 | $185 |
| Inspire Medical Systems, Inc. | 2 | $138 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $125 |
| Recor Medical Inc | 1 | $117 |
| Alnylam Pharmaceuticals Inc. | 3 | $88 |
| Novo Nordisk Inc | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
Products named: REPATHA, VERQUVO, INSPIRE, ELIQUIS, LEQVIO, Paradise Ultrasound Renal Denervation System, CAMZYOS, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
